What caused CTSO's EPS to drop sharply in Q3 2024?

The EPS of Cytosorbents Co. (NASDAQ:CTSO) is forecasted to drop sharply in Q3 2024 due to a combination of factors:

1. **Decreased Revenue Projections**: Both HC Wainwright and B. Riley have decreased their revenue estimates for Q3 2024 compared to the previous quarter. This indicates a potential decline in the company's profitability.
2. **Higher Expenses**: There is a likelihood of increased expenses, which can negatively impact the net income and, consequently, the EPS. For instance, B. Riley's report suggests that Cytosorbents may incur higher expenses, leading to a reduction in EPS.

In summary, the combination of decreased revenue projections and higher expenses is likely to result in a significant drop in Cytosorbents Co.'s EPS in Q3 2024.